The valve, designed with a new-look sealing cuff for limiting paravalvular regurgitation, gained FDA approval in January 2023. 

“The Evolut FX system is an improvement over previous Evolut system devices and it delivers better overall results to our patients,” says interventional cardiologist Guilherme Attizzani, MD. “It is an ideal solution for a majority of our patients.”

Researchers in India performed TAVR on two relatively young patients with a preexisting mechanical mitral valve, sharing their experience in a new case report. The group highlighted the importance of planning ahead.

Asian patients are rarely represented in large TAVR trials, the authors wrote, so they focused on nearly 1,200 patients from South Korea to provide a fresh perspective. 

A majority of strokes after TAVR occur in the first 48 hours, but patients remain at a significantly higher risk for much longer. 

Hospitals should be making every effort to help sonographers deliver better, more accurate echocardiograms and improve the diagnosis of severe aortic stenosis. If you take care of your sonographers, your sonographers will take care of you. 

“These findings are highly pertinent in a clinical setting," researchers explained. 

Valve-in-valve TAVR outperforms redo SAVR for the first six months after treatment, according to a new meta-analysis published in the American Journal of Cardiology. Then, however, things begin to shift.

The new study included data on patients who presented for TAVR with preexisting AFib as well as those who developed new-onset AFib after the procedure.